Improving the role of immune checkpoint inhibitors in the management of advanced urothelial carcinoma, where do we stand?
-
Published:2022-05
Issue:
Volume:19
Page:101387
-
ISSN:1936-5233
-
Container-title:Translational Oncology
-
language:en
-
Short-container-title:Translational Oncology
Author:
Houssiau Hélène,
Seront EmmanuelORCID
Subject
Cancer Research,Oncology
Reference58 articles.
1. Cancer statistics;Siegel;CA Cancer J. Clin.,2018
2. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1054 patients;Stein;J. Clin. Oncol.,2001
3. Intracavitary bacillus calmette-guerin in the treatment of superficial bladder tumors;Morales;J. Urol.,1976
4. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer;Grossman;N. Engl. J. Med.,2003
5. Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study;von der Maase;J. Clin. Oncol.,2000
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献